about
Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancerProspects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant LesionsPrediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers.Enhancement of photodynamic antitumor effect with pro-oxidant ascorbate.Photodynamic therapy for the treatment of induced mammary tumor in rats.Targeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT)Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration.EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies.Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugatesSulfonated Polyethylenimine for Photosensitizer Conjugation and TargetingOptimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer.Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy.Strategies for enhanced photodynamic therapy effects.PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.The role of photodynamic therapy (PDT) physics.A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.Targeted photodynamic therapy--a promising strategy of tumor treatment.In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy.A novel photosensitizer: An l-glutamide lipid conjugate with improved properties for photodynamic therapy.Hiporfin-mediated photodynamic therapy in preclinical treatment of osteosarcoma.Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro.Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)chlorin (m-THPC).Remarkable photocytotoxicity of a novel triazole-linked cationic porphyrin-β-carboline conjugate.A phthalocyanine-peptide conjugate with high in vitro photodynamic activity and enhanced in vivo tumor-retention property.Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.Phthalocyanine-polyamine conjugates as pH-controlled photosensitizers for photodynamic therapy.Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer.Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy.Enhanced cellular uptake of chlorine e6 mediated by stearic acid-grafted chitosan oligosaccharide micelles.An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.Light Harvesting and Photoemission by Nanoparticles for Photodynamic Therapy
P2860
Q26800059-D67A4FB1-F271-4367-9046-7FFB5423041CQ27692631-82B69327-D3EA-4019-BE0F-90A632F3BE9AQ30422124-4E36B9D5-E95B-4B0A-87C9-8DFFE643735DQ33588136-A94DD515-15CE-4765-A6FC-8F34A2054084Q34108491-D0632A5E-255F-4318-852D-8A4BCDEE1C16Q34128139-283CB35A-F5D9-4EBE-BA67-103D9A82F50BQ34260731-B08E6CF5-3D2C-42BB-B970-DBB5902D50D3Q34927053-1DCFDC21-B61C-44BD-9511-264073C318F8Q35540652-D5447595-48EB-4CEE-8964-F88B061CBF82Q35851952-FA54F09B-C9B5-4236-B7D4-89C826576380Q35868119-5F87D795-5EB7-4A4A-9AE2-544E1559AEAAQ36297281-55DD412F-B729-4886-94DF-32C09DC37FE7Q36400084-A7E088A3-0934-4ED7-B11D-3574BBC9EE90Q36524232-5DF897A0-BC81-49F8-8510-B000014B3F1DQ36790826-F9A9C20F-8079-43F3-8749-B306423E7436Q36875123-ACB906BE-913E-4640-A55F-3EC6972260D3Q36945978-22033E3F-5C4B-41B6-A09F-91CC88642093Q36983114-2E979E30-2208-4E15-8035-EE6A9E83ABB9Q37170164-5ADF3B61-7598-41ED-8E63-B0D15E0F2B04Q37190425-C2AC21D2-B8E9-4F31-8393-287B1DC2FF91Q37872626-C64BA9E4-2AAA-4BF3-99A3-4DBBE0BC80EEQ38244010-6AB07DE3-5A34-4F06-9546-83E9548AE76FQ38729687-87D0246E-34E1-47AF-BA87-DB31D5CF2AACQ38916697-308B4FAA-BAC3-4EB7-80F7-5C7383D55AEBQ39047491-DA53CCEB-118E-48F7-9C71-31C8430678C1Q39198868-8767C6F4-F1AC-4FA4-B7AD-692647DDAC61Q39229960-F38578CB-38F7-487B-83D6-8C01B1FF8431Q39387977-32F1AE78-B48B-4E28-B476-A2A320EB0B0BQ39518754-1A745DAF-829F-40E8-8E10-384AFB22EA48Q39724362-F09A6B23-80E8-4DDE-8B8D-EAAD4E5A9D2CQ39827124-525B9998-E9E3-4485-8D0E-126040EE72C3Q46569263-92272E9D-910D-4FCE-A10D-C061D41CC716Q50613187-94320F17-A1F7-44E9-889D-269DE74E4629Q55285087-CD84D157-C5F0-4634-9A4E-E48707C5DF5CQ57345360-B41CB9B3-5B94-450E-984C-354C99795104
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Targeted photodynamic therapy.
@ast
Targeted photodynamic therapy.
@en
type
label
Targeted photodynamic therapy.
@ast
Targeted photodynamic therapy.
@en
prefLabel
Targeted photodynamic therapy.
@ast
Targeted photodynamic therapy.
@en
P356
P1476
Targeted photodynamic therapy.
@en
P2093
Nicolas Solban
Tayyaba Hasan
P304
P356
10.1002/LSM.20345
P50
P577
2006-06-01T00:00:00Z